RU2555765C2 - Пироксикам для профилактического и терапевтического лечения герпетических инфекций - Google Patents
Пироксикам для профилактического и терапевтического лечения герпетических инфекций Download PDFInfo
- Publication number
- RU2555765C2 RU2555765C2 RU2012147474/15A RU2012147474A RU2555765C2 RU 2555765 C2 RU2555765 C2 RU 2555765C2 RU 2012147474/15 A RU2012147474/15 A RU 2012147474/15A RU 2012147474 A RU2012147474 A RU 2012147474A RU 2555765 C2 RU2555765 C2 RU 2555765C2
- Authority
- RU
- Russia
- Prior art keywords
- infections
- tool according
- piroxicam
- therapeutic treatment
- preventive
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 5
- 208000015181 infectious disease Diseases 0.000 title claims description 14
- 230000003449 preventive effect Effects 0.000 title abstract 2
- 208000036142 Viral infection Diseases 0.000 claims abstract description 7
- 230000009385 viral infection Effects 0.000 claims abstract description 7
- 241000700605 Viruses Species 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 6
- 230000003253 viricidal effect Effects 0.000 claims abstract description 4
- 241000700586 Herpesviridae Species 0.000 claims abstract description 3
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 229960002702 piroxicam Drugs 0.000 claims description 11
- 208000009889 Herpes Simplex Diseases 0.000 claims description 5
- 230000000069 prophylactic effect Effects 0.000 claims description 4
- 208000004898 Herpes Labialis Diseases 0.000 claims description 3
- 206010067152 Oral herpes Diseases 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 238000001802 infusion Methods 0.000 claims description 2
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- 229940098465 tincture Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 2
- 208000010201 Exanthema Diseases 0.000 description 6
- 239000013543 active substance Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 201000005884 exanthem Diseases 0.000 description 6
- 206010037844 rash Diseases 0.000 description 6
- 208000007514 Herpes zoster Diseases 0.000 description 5
- 229960001259 diclofenac Drugs 0.000 description 5
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 241001529453 unidentified herpesvirus Species 0.000 description 5
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 4
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 4
- 239000000499 gel Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010019973 Herpes virus infection Diseases 0.000 description 2
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 229960004752 ketorolac Drugs 0.000 description 2
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 2
- YNPZRWAUSSZALM-UHFFFAOYSA-N 1,1-dioxo-2-pyridin-2-yl-1$l^{6},2-benzothiazine-3-carboxamide Chemical compound NC(=O)C1=CC2=CC=CC=C2S(=O)(=O)N1C1=CC=CC=N1 YNPZRWAUSSZALM-UHFFFAOYSA-N 0.000 description 1
- 229940124638 COX inhibitor Drugs 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical group N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003602 anti-herpes Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 201000011486 lichen planus Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000001032 spinal nerve Anatomy 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102010014290.5 | 2010-04-08 | ||
| DE102010014290A DE102010014290A1 (de) | 2010-04-08 | 2010-04-08 | Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen |
| PCT/EP2011/001704 WO2011124366A1 (de) | 2010-04-08 | 2011-04-06 | Piroxicam zur prophylaktischen und therapeutischen behandlung von herpes - infektionen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2012147474A RU2012147474A (ru) | 2014-05-20 |
| RU2555765C2 true RU2555765C2 (ru) | 2015-07-10 |
Family
ID=43970974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012147474/15A RU2555765C2 (ru) | 2010-04-08 | 2011-04-06 | Пироксикам для профилактического и терапевтического лечения герпетических инфекций |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20130190301A1 (enExample) |
| EP (1) | EP2374461B1 (enExample) |
| JP (1) | JP6158077B6 (enExample) |
| CN (1) | CN103153312B (enExample) |
| CA (1) | CA2795334C (enExample) |
| DE (1) | DE102010014290A1 (enExample) |
| DK (1) | DK2374461T3 (enExample) |
| ES (1) | ES2612584T3 (enExample) |
| PL (1) | PL2374461T3 (enExample) |
| RU (1) | RU2555765C2 (enExample) |
| WO (1) | WO2011124366A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102010014290A1 (de) * | 2010-04-08 | 2011-10-13 | Hans Otto Meyer zu Spelbrink | Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen |
| DE102013003756A1 (de) | 2013-03-06 | 2014-09-11 | DeaValorum UG (haftungsbeschränkt) | Piroxicam zur prophylaktischen und therapeutischen Behandlung von CMV-Infektionen |
| DE102013014787A1 (de) | 2013-09-09 | 2015-03-12 | Dauphine UG (haftungsbeschränkt) | Mittel zur prophylaktischen und therapeutischen Behandlung von EHV-Infektionen |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2182016C2 (ru) * | 1997-03-20 | 2002-05-10 | Панацея Биотек Лтд. | Спазмолитическая композиция, способ получения спазмолитической композиции |
| US7132452B2 (en) * | 2003-03-10 | 2006-11-07 | Fang-Yu Lee | Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3437232A1 (de) * | 1984-10-10 | 1986-04-17 | Mack Chem Pharm | Stabilisierte injektionsloesungen von piroxicam |
| IT1216686B (it) * | 1988-04-01 | 1990-03-08 | Chiesi Farma Spa | Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione. |
| IT1230922B (it) * | 1989-06-23 | 1991-11-08 | Giuseppe De Benedittis | Composizione per il trattamento della nevralgia erpetica acuta e della nevralgia post erpetica |
| EP0453603B1 (de) * | 1990-04-26 | 1993-10-06 | Sagitta Arzneimittel Gmbh | Piroxicam enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung |
| JP3031990B2 (ja) * | 1990-10-19 | 2000-04-10 | 同仁医薬化工株式会社 | 消炎鎮痛クリーム剤組成物 |
| DE10300222A1 (de) * | 2003-01-03 | 2004-07-15 | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH | Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen |
| DE102010014290A1 (de) * | 2010-04-08 | 2011-10-13 | Hans Otto Meyer zu Spelbrink | Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen |
-
2010
- 2010-04-08 DE DE102010014290A patent/DE102010014290A1/de not_active Ceased
-
2011
- 2011-03-04 PL PL11001816T patent/PL2374461T3/pl unknown
- 2011-03-04 EP EP11001816.5A patent/EP2374461B1/de active Active
- 2011-03-04 DK DK11001816.5T patent/DK2374461T3/en active
- 2011-03-04 ES ES11001816.5T patent/ES2612584T3/es active Active
- 2011-04-06 WO PCT/EP2011/001704 patent/WO2011124366A1/de not_active Ceased
- 2011-04-06 US US13/639,357 patent/US20130190301A1/en not_active Abandoned
- 2011-04-06 JP JP2013503032A patent/JP6158077B6/ja not_active Expired - Fee Related
- 2011-04-06 RU RU2012147474/15A patent/RU2555765C2/ru active
- 2011-04-06 CN CN201180021384.XA patent/CN103153312B/zh not_active Expired - Fee Related
- 2011-04-06 CA CA2795334A patent/CA2795334C/en active Active
-
2014
- 2014-01-29 US US14/167,676 patent/US20140148447A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2182016C2 (ru) * | 1997-03-20 | 2002-05-10 | Панацея Биотек Лтд. | Спазмолитическая композиция, способ получения спазмолитической композиции |
| US7132452B2 (en) * | 2003-03-10 | 2006-11-07 | Fang-Yu Lee | Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2612584T3 (es) | 2017-05-17 |
| US20140148447A1 (en) | 2014-05-29 |
| DE102010014290A1 (de) | 2011-10-13 |
| CA2795334C (en) | 2015-06-09 |
| JP6158077B6 (ja) | 2018-08-29 |
| CN103153312A (zh) | 2013-06-12 |
| WO2011124366A1 (de) | 2011-10-13 |
| US20130190301A1 (en) | 2013-07-25 |
| CN103153312B (zh) | 2015-07-22 |
| EP2374461A1 (de) | 2011-10-12 |
| PL2374461T3 (pl) | 2017-08-31 |
| JP2013523789A (ja) | 2013-06-17 |
| JP6158077B2 (ja) | 2017-07-05 |
| RU2012147474A (ru) | 2014-05-20 |
| EP2374461B1 (de) | 2016-10-26 |
| CA2795334A1 (en) | 2011-10-13 |
| DK2374461T3 (en) | 2017-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2004251720B2 (en) | Method for treatment of sores and lesions of the skin | |
| EP1998758A1 (en) | Spray composition for topical use for treating and/or preventing herpes simplex labial infections | |
| Burgess et al. | Review of over-the-counter treatments for aphthous ulceration and results from use of a dissolving oral patch containing glycyrrhiza complex herbal extract | |
| WO2021207325A1 (en) | Natural extract and their components for use in mitigating acute respiratory distress syndrome | |
| JP2025166032A (ja) | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 | |
| RU2555765C2 (ru) | Пироксикам для профилактического и терапевтического лечения герпетических инфекций | |
| JP2008543885A (ja) | 皮膚病変治療用組成物 | |
| JP2000512270A (ja) | 単純ヘルペスの処置のための組成物および方法 | |
| WO2015072853A1 (en) | Treatment of herpes virus infection outbreaks | |
| US20170020946A1 (en) | Analgesic compositions and methods of use | |
| BE1019216A3 (nl) | Kleefpleister voor de toediening van therapeutische agentia. | |
| ES2447829T3 (es) | Combinación para el tratamiento de la osteoartritis | |
| CN101461817A (zh) | 1,2,3,4,6-五-O-没食子酰基-b-D-葡萄糖的用途 | |
| JP2017132819A (ja) | ロキソプロフェン又はその塩含有の医薬組成物 | |
| RU2241443C1 (ru) | Фармацевтическая композиция для лечения герпес-вирусной инфекции | |
| JP6830482B2 (ja) | 粘膜病変の治療のための配合物 | |
| RU2834677C1 (ru) | Полимеры двойного действия в осмотической пленке для топического применения с целью лечения воспалительных заболеваний и синдрома высвобождения цитокинов | |
| US20060287364A1 (en) | Methods of prevention of infection with HIV/AIDS, venereal disease and influenza | |
| KR20190040185A (ko) | 바이러스 감염의 치료에서 활성제로서의 키보르놀(xibornol)의 용도 | |
| WO2015072852A1 (en) | Treatment of herpes virus infection outbreaks using valerian | |
| CN116390763A (zh) | 用于局部应用以治疗炎性疾病和细胞因子释放综合征的渗透膜中的双重作用聚合物 | |
| SK1292006A3 (sk) | Liečivý prípravok na hojenie oparov | |
| SK5161Y1 (sk) | Liečivý prípravok na hojenie oparov |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HZ9A | Changing address for correspondence with an applicant | ||
| PC41 | Official registration of the transfer of exclusive right |
Effective date: 20190429 |